Changes in receptor responsiveness
| Term | Meaning |
|---|---|
| Desensitization | A reduced response to a given stimulus. |
| Internalization | Movement of receptors from the surface into the cell. |
| Downregulation | A reduction in the available receptor population. |
| Recycling | Return of internalized receptors to the membrane. |
| Resensitization | Recovery of a previously reduced response. |
A weaker response does not always mean fewer receptors. Changes in coupling can reduce a signal while receptors remain present. The relevant measurement must therefore be specified.
Phosphorylation and beta-arrestin
Activated receptors can be phosphorylated by G-protein-coupled receptor kinases. Beta-arrestin can then bind and limit coupling to the original G-protein pathway. These interactions help a cell regulate repeated stimulation.
Some internalized receptors return to the membrane; others are sent toward degradation. New receptor production and changes in downstream proteins also contribute to recovery. The experimental beta-arrestin literature describes regulation at this molecular level.
Repeated stimulation in human muscle
Human muscle research has found weaker activation of parts of the beta2 signaling pathway during repeated exposure, even while a lean-tissue response remained measurable. This illustrates why tolerance should refer to a particular endpoint.
A biopsy measures signaling in sampled muscle. It does not measure every response in fat tissue, airways or the heart. The controlled human trials place those laboratory findings alongside body-composition and performance outcomes.
Tremor and subjective stimulation
Hand tremor can change with stress, caffeine, fatigue and the task being performed. A person may also become less aware of a familiar sensation. Neither observation measures the number of receptors in fat cells.
Increasing exposure to reproduce the first day's sensation can add drug without establishing an additional useful effect. An unexpected change in sensation may also reflect a different product strength or uncertain contents.
Drug clearance and receptor recovery
Elimination lowers the amount of drug in the body. Receptor recovery changes the way cells respond. These are separate processes, so their timelines need not match.
During repeated use, the amount present can accumulate while a particular response weakens. A scheduled break therefore cannot establish full recovery across all tissues. Duration and accumulation explains the pharmacokinetic part of this process.
Ketotifen and sensitivity
Older ketotifen studies examined immune-cell responses and airway sensitivity. Those findings have been used to support much broader claims in fitness discussions.
They do not establish a validated method of prolonging a bodybuilding cycle. The ketotifen comparison identifies the tissues studied and what the experiments actually tested.